CONSORT 2010 statement: extension checklist for reporting within person randomised trials

N. Pandis, B. Chung, Roberta Scherer, D. Elbourne, D. G. Altman

Research output: Contribution to journalArticle

Abstract

Evidence shows that the quality of reporting of randomised controlled trials (RCTs) is not optimal. The lack of transparent reporting impedes readers from judging the reliability and validity of trial findings and researchers from extracting information for systematic reviews and results in research waste. The Consolidated Standards of Reporting Trials (CONSORT) statement was developed to improve the reporting of RCTs. Within person trials are used for conditions that can affect two or more body sites, and are a useful and efficient tool because the comparisons between interventions are within people. Such trials are most commonly conducted in ophthalmology, dentistry, and dermatology. The reporting of within person trials has, however, been variable and incomplete, hindering their use in clinical decision making and by future researchers. This document presents the CONSORT extension to within person trials. It aims to facilitate the reporting of these trials. It extends 16 items of the CONSORT 2010 checklist and introduces a modified flowchart and baseline table to enhance transparency. Examples of good reporting and evidence based rationale for CONSORT within person checklist items are provided.

Original languageEnglish (US)
JournalBritish Journal of Dermatology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Checklist
Randomized Controlled Trials
Research Personnel
Software Design
Ophthalmology
Dermatology
Dentistry
Reproducibility of Results
Research

ASJC Scopus subject areas

  • Dermatology

Cite this

CONSORT 2010 statement : extension checklist for reporting within person randomised trials. / Pandis, N.; Chung, B.; Scherer, Roberta; Elbourne, D.; Altman, D. G.

In: British Journal of Dermatology, 01.01.2019.

Research output: Contribution to journalArticle

@article{64ca3500e31d4435909638df2a76f5a1,
title = "CONSORT 2010 statement: extension checklist for reporting within person randomised trials",
abstract = "Evidence shows that the quality of reporting of randomised controlled trials (RCTs) is not optimal. The lack of transparent reporting impedes readers from judging the reliability and validity of trial findings and researchers from extracting information for systematic reviews and results in research waste. The Consolidated Standards of Reporting Trials (CONSORT) statement was developed to improve the reporting of RCTs. Within person trials are used for conditions that can affect two or more body sites, and are a useful and efficient tool because the comparisons between interventions are within people. Such trials are most commonly conducted in ophthalmology, dentistry, and dermatology. The reporting of within person trials has, however, been variable and incomplete, hindering their use in clinical decision making and by future researchers. This document presents the CONSORT extension to within person trials. It aims to facilitate the reporting of these trials. It extends 16 items of the CONSORT 2010 checklist and introduces a modified flowchart and baseline table to enhance transparency. Examples of good reporting and evidence based rationale for CONSORT within person checklist items are provided.",
author = "N. Pandis and B. Chung and Roberta Scherer and D. Elbourne and Altman, {D. G.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/bjd.17239",
language = "English (US)",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - CONSORT 2010 statement

T2 - extension checklist for reporting within person randomised trials

AU - Pandis, N.

AU - Chung, B.

AU - Scherer, Roberta

AU - Elbourne, D.

AU - Altman, D. G.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Evidence shows that the quality of reporting of randomised controlled trials (RCTs) is not optimal. The lack of transparent reporting impedes readers from judging the reliability and validity of trial findings and researchers from extracting information for systematic reviews and results in research waste. The Consolidated Standards of Reporting Trials (CONSORT) statement was developed to improve the reporting of RCTs. Within person trials are used for conditions that can affect two or more body sites, and are a useful and efficient tool because the comparisons between interventions are within people. Such trials are most commonly conducted in ophthalmology, dentistry, and dermatology. The reporting of within person trials has, however, been variable and incomplete, hindering their use in clinical decision making and by future researchers. This document presents the CONSORT extension to within person trials. It aims to facilitate the reporting of these trials. It extends 16 items of the CONSORT 2010 checklist and introduces a modified flowchart and baseline table to enhance transparency. Examples of good reporting and evidence based rationale for CONSORT within person checklist items are provided.

AB - Evidence shows that the quality of reporting of randomised controlled trials (RCTs) is not optimal. The lack of transparent reporting impedes readers from judging the reliability and validity of trial findings and researchers from extracting information for systematic reviews and results in research waste. The Consolidated Standards of Reporting Trials (CONSORT) statement was developed to improve the reporting of RCTs. Within person trials are used for conditions that can affect two or more body sites, and are a useful and efficient tool because the comparisons between interventions are within people. Such trials are most commonly conducted in ophthalmology, dentistry, and dermatology. The reporting of within person trials has, however, been variable and incomplete, hindering their use in clinical decision making and by future researchers. This document presents the CONSORT extension to within person trials. It aims to facilitate the reporting of these trials. It extends 16 items of the CONSORT 2010 checklist and introduces a modified flowchart and baseline table to enhance transparency. Examples of good reporting and evidence based rationale for CONSORT within person checklist items are provided.

UR - http://www.scopus.com/inward/record.url?scp=85059511226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059511226&partnerID=8YFLogxK

U2 - 10.1111/bjd.17239

DO - 10.1111/bjd.17239

M3 - Article

C2 - 30609010

AN - SCOPUS:85059511226

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

ER -